High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment-Reference-Cited by-同舟云学术

High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment

Published:2003-06-23 Issue:1 Volume:32 Page:97-102
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Juvonen E,Aalto S M,Tarkkanen J,Volin L,Mattila P S,Knuutila S,Ruutu T,Hedman K

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704089.pdf

Reference24 articles.

1. Cohen JI . Epstein-Barr virus infection. N Engl J Med 2000; 343: 481–492.

2. Swinnen LJ . Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 2000; 11 (Suppl. 1): 45–48.

3. Paya CV, Fung JJ, Nalesnik MA et al. Epstein–Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999; 68: 1517–1525.

4. Lucas KG, Burton RL, Zimmerman SE et al. Semiquantitative Epstein–Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 1998; 91: 3654–3661.

5. Curtis RE, Travis LB, Rowlings PA et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208–2216.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes;International Journal of Molecular Sciences;2023-11-07

2. Epidemiology and Prognosis of PTLD After HSCT;Post-Transplant Lymphoproliferative Disorders;2021

3. Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes;Bone Marrow Transplantation;2020-02-17

4. Post Transplant Lymphoproliferative Disorder;Indian Journal of Hematology and Blood Transfusion;2019-09-17

5. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation;Pediatric Transplantation;2018-11-11